Burzynski Research Institute Inc (BZYR) — 10-Q Filings

10-Q Filings (6)

• Burzynski Research Institute Narrows Loss Amid FDA Hold, Funding Reliance — Oct 14, 2025 Risk: high
  Burzynski Research Institute, Inc. (BZYR) reported a net loss of $333,867 for the three months ended August 31, 2025, a 9.7% improvement from the $369,838 net l
• Burzynski Research Institute Q1 Equity Shifts Noted — Jul 15, 2025 Risk: high
  Burzynski Research Institute, Inc. (BZYR) filed its 10-Q for the quarter ended May 31, 2025, indicating no significant revenue or net income figures were disclo
• Burzynski Research Institute Files Q3 2025 10-Q — Jan 13, 2025 Risk: low
  Burzynski Research Institute Inc. filed its 10-Q for the period ending November 30, 2024. The filing details financial information for the third quarter of fisc
• Burzynski Research Institute Inc. Files 10-Q — Oct 10, 2024 Risk: low
  Burzynski Research Institute Inc. filed its 10-Q for the period ending August 31, 2024. The filing details financial information including retained earnings and
• Burzynski Research Institute Inc. Files 10-Q — Jul 15, 2024 Risk: low
  Burzynski Research Institute Inc. filed its 10-Q for the period ending May 31, 2024. The company's fiscal year ends on February 29th. Key financial statement da
• Burzynski Research Institute Inc. Files 10-Q for Period Ending November 30, 2023 — Jan 16, 2024 Risk: low
  BURZYNSKI RESEARCH INSTITUTE INC (BZYR) filed a Quarterly Report (10-Q) with the SEC on January 16, 2024. The filing is a 10-Q for Burzynski Research Institute

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX